Skip to main content
. 2018 Mar 28;34(3):347–352. doi: 10.1007/s12640-018-9890-6

Table 3.

Clinical characteristics of population with NLR ≤ 7.35 and NLR > 7.35

Low-NLR group
(≤ 7.35, n = 107)
High-NLR group
(> 7.35, n = 74)
P
Age (years); mean ± SD 65.0 ± 13.9 67.1 ± 14.8 0.327
Age ≥ 80 years [n (%)] 20 (18.7) 19 (25.7) 0.261
Male [n (%)] 65 (60.7) 47 (63.5) 0.706
Hypertension [n (%)] 93 (86.9) 63 (85.1) 0.733
Diabetes mellitus [n (%)] 25 (23.4) 18 (24.3) 0.881
Supratentorial origin [n (%)] 96 (89.7) 70 (94.6) 0.242
Presence of IVH [n (%)] 18 (16.8) 22 (29.7) 0.040
ICH volume (cm3); median (IQR) 6.0 (10.9) 23.9 (41.3) < 0.001
GCS score, mean ± SD 12.9 ± 3.2 9.4 ± 4.5 < 0.001
ICH score, median (IQR) 0 (1) 1.5 (2) < 0.001
Time from ICH onset to sample collection, hours, mean ± SD 14.0 ± 6.8 15.9 ± 7.0 0.066
Systolic BP (mmHg), mean ± SD 157.5 ± 24.2 161.5 ± 26.3 0.297
Diastolic BP (mmHg), mean ± SD 89.1 ± 14.6 95.9 ± 17.0 0.005
WBC (*109/L), median (IQR) 8.3 (4.2) 11.8 (6.5) < 0.001
Neutrophil (*109/L), median (IQR) 5.1 (2.9) 9.7 (5.1) < 0.001
Lymphocyte (*109/L), median (IQR) 1.4 (0.5) 0.8 (0.4) < 0.001
NLR, median (IQR) 3.7 (2.2) 11.5 (11.1) < 0.001
CRP (mg/L); median (IQR) 6 (16.5) 29 (68.5) < 0.001
Fibrinogen (mg/dl); mean ± SD 3.4 ± 0.9 3.7 ± 1.0 0.114
30-day mortality [n (%)] 7 (6.5) 28 (37.8) < 0.001